Login to Your Account


Lymphedema responds to anti-inflammatory drug: Researcher

By Anette Breindl
Senior Science Editor

Wednesday, May 10, 2017

A new way of conceptualizing lymphedema has led to the discovery of a new way to treat it. The approach is now being tested in a phase II trial. Lymphedema patients, which number several million in the U.S., "should feel extraordinary hope for the future," Stanley Rockson told BioWorld Today.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription